Surya Eye Institute & Research Centre Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 15-12-2024
- Paid Up Capital ₹ 4.92 M
as on 15-12-2024
- Company Age 28 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.15 M
as on 15-12-2024
- Revenue 74.10%
(FY 2022)
- Profit 1605.39%
(FY 2022)
- Ebitda 100.67%
(FY 2022)
- Net Worth 128.82%
(FY 2022)
- Total Assets 4.14%
(FY 2022)
About Surya Eye Institute & Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 4.92 M.
The company has closed loans amounting to ₹3.15 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Neelam Goyel, Vinod Rameshwar, and Jay Vinod serve as directors at the Company.
- CIN/LLPIN
U85110MH1996PTC103903
- Company No.
103903
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Surya Eye Institute & Research Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jay Vinod  | Director | 28-Aug-2023 | Current |
| Neelam Goyel | Director | 30-Sep-2000 | Current |
| Vinod Rameshwar | Director | 11-Nov-1996 | Current |
Financial Performance of Surya Eye Institute & Research Centre.
Surya Eye Institute & Research Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 74.1% increase. The company also saw a substantial improvement in profitability, with a 1605.39% increase in profit. The company's net worth Soared by an impressive increase of 128.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surya Eye Institute & Research Centre?
In 2022, Surya Eye Institute & Research Centre had a public holding of 74.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
C-Quick Lasik Laser Centre Private LimitedActive 8 years 4 monthsNeelam Goyel and Jay Vinod are mutual person
- Jay Vision Care And Ophthalmics Private LimitedActive 22 years 11 months
Neelam Goyel and Jay Vinod are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Saraswat Co-Oprative Bank Limited Creation Date: 31 Mar 2000 | ₹3.15 M | Satisfied |
How Many Employees Work at Surya Eye Institute & Research Centre?
Unlock and access historical data on people associated with Surya Eye Institute & Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surya Eye Institute & Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surya Eye Institute & Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
